申请人:Symrise AG
公开号:US11332692B2
公开(公告)日:2022-05-17
The invention relates to a preparation containing: (i) a composition containing (a) one, two or a plurality of compounds selected from the group consisting of (a1) alcohol monoterpenes of formula (I) in which R1 is H or methyl, R2 is H or C2-alkenyl, und R3 is a linear or branched, saturated or unsaturated hydrocarbon radical with 4 to 10 carbon atoms, and the enantiomers, diastereomers, racemates, solvates and physiologically compatible salts thereof, and/or (a2) bicyclic epoxy-monoterpenes, (b) at least two lactones of formula (II) in which R4 is H or methyl, R5 is a linear or branched, saturated or unsaturated hydrocarbon radical with 2 to 10 hydrocarbon atoms and n is the number 1 or 2, and the enantiomers, diastereomers and racemates thereof, (c) one, two or a plurality of solvents selected from the group consisting of ethanol, water, dipropylene glycol (DPG), diethyl phtalate (DEP), propylene glycol (PG), isopropyl myristate (IPM), isopropyl palmitate (IPP), triethyl citrate (TEC), triacetin (TRI), 1,2-Propanediol, 1,3-Propanediol, Propanethiol, Pentanediol, Hexanediol, Octanediol, Decanediol (SymClariol®), Dodecanol, 4-hydroxy-acetophenone (SymSave® H), glycerine, butylene glycol, pentylene glycol, hexylene glycol, decylene glycol, propylene carbonate, butylene carbonate, glycerine carbonate, 2-5 benzyl heptanol, lauryl alcohol, trimethyl-hydroxypentyl-isobutyrate, glyceryl-caprylate, ethylhexyl glycerine, benzyl benzoate (BB), and optionally (d) other flavouring agents or aromatic substances selected from the group consisting of 3-phenylbutanal (Trifernal), acetyl methyl carbinol, anethole, anisyl acetate, dihydroeugenol, linalyl formate, 2-methyldecanal, 2-benzyl-2-methylbut-3-ene nitrile (Ci-Trowanil® B), 3-hexenyl acetate, styrallyl acetate, belanis, citronellal, cinnamyl acetate, rhubafuran, beta-ions, anther, prenyl acetate, 2-phenyl propanal, 4-(4-hydroxyphenyl)butan-2-one (Frambinon®), ethyl phenoxyacetate, isoralderine, gamma-terpinene, limonene, neocyclocitral, methyl lavender ketone, styrallyl propionate, phenyl ethyl propionate, limonenal, 4-isopentylcyclohexanol (Symrose®), 4-methyl-2-phenyl-3,6-dihydro-2H-pyran/4-methylene-2-phenyl-tetrahydropyrane (Rosyrane super), hydrocitronitril, phenoxanol, isoamyl phenylacetate, damascone, silvial, nectaryl, ambroxide, acetyl pyrazine, trimethyl pyrazine, isoamyl acetate, para-cresyl methyl ether, filbertone, cyclohexyl acetate, heliotropin, acetophenone, anisaldehyde, para-methyl acetophenone, veratraldehyde, methyl anisate and vertoprenal; (ii) aldehydes of formula (III) in which R6 is a saturated or non-saturated, linear hydrocarbon radical; and/or (iii) free fatty acids of formula (IV), in which R7 is a linear or branched, saturated hydrocarbon radical.
本发明涉及一种含有以下成分的制剂(i) 含有(a)一种、两种或多种选自以下组别的化合物的组合物 (a1)式(I)醇单萜烯,其中 R1 是 H 或甲基,R2 是 H 或 C2-烯基,und R3 是具有 4 至 10 个碳原子的线性或支链、饱和或不饱和烃基,以及其对映体、非对映体、外消旋体、溶物和生理相容盐,和/或 (a2)双环环氧单萜烯、(a2) 双环环氧单萜,(b) 至少两个式(II)的内酯,其中 R4 是 H 或甲基,R5 是具有 2 至 10 个碳原子的线性或支链饱和或不饱和烃基,n 是数字 1 或 2、及其对映体、非对映体和外消旋体, (c) 一种、两种或多种溶剂,选自乙醇、水、二丙二醇(DPG)、乙酸二乙酯 (DEP)、丙二醇(PG)、肉豆蔻酸异丙酯(IPM)、棕榈酸异丙酯(IPP)、 柠檬酸三乙酯(TEC)组成的溶剂组、三醋精(TRI)、1,2-丙二醇、1,3-丙二醇、丙硫醇、戊二醇、己二醇、辛二醇、癸二醇(SymClariol®)、十二醇、4-羟基苯乙酮(SymSave® H)、甘油、丁二醇、戊二醇、己二醇、癸二醇、碳酸丙烯酯、碳酸丁烯酯、碳酸甘油酯、2-5-苄基庚醇、月桂醇、三甲基羟基戊基异丁酸酯、丙烯酸甘油酯、乙基己基甘油酯、苯甲酸苄酯 (BB),以及可选的 (d) 其他调味剂或芳香物质,选自 3-苯基丁醛(Trifernal)、乙酰甲基甲醇茴香醚、乙酸茴香酯、二氢丁香酚、甲酸芳樟酯、2-甲基癸醛、2-苄基-2-甲基丁-3-烯腈(Ci-Trowanil® B)、乙酸 3-己烯酯、乙酸苯乙烯烯酯、香茅醛、乙酸肉桂酯、呋喃西林、β-离子、花药、乙酸炔丙酯、2-苯基丙醛、4-(4-羟基苯基)丁-2-酮(Frambinon®)、苯氧乙酸乙酯、异橙皮醚、γ-萜品烯、柠檬烯、新环柠檬醛、甲基薰衣草酮、丙酸苯乙烯酯、丙酸苯乙酯、柠檬烯醛、4-异戊基环己醇(Symrose®)、4-甲基-2-苯基-3,6-二氢-2H-吡喃/4-亚甲基-2-苯基-四氢吡喃(Rosyrane super)、氢化硝基甲苯、phenoxanol, isoamyl phenylacetate, damascone, silvial, nectaryl, ambroxide, acetyl pyrazine, trimethyl pyrazine, isoamyl acetate, para-cresyl methyl ether, filbertone, cyclohexyl acetate, heliotropin, acetophenone, anisaldehyde, para-methyl acetophenone, veratraldehyde, methyl anisate and vertoprenal;(ii) 式(III)中 R6 为饱和或非饱和线性烃基的醛类;和/或 (iii) 式(IV)中 R7 为线性或支链饱和烃基的游离脂肪酸。